CRTH2 antagonists in asthma: current perspectives.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 165, doi. 10.2147/CPAA.S119295
- By:
- Publication type:
- Article
Works matching IS 11791438 AND DT 2017 AND VI 9
Results: 18
1
2
Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 125, doi. 10.2147/CPAA.S147835
- By:
- Publication type:
- Article
3
Role of afatinib in the treatment of advanced lung squamous cell carcinoma.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 147, doi. 10.2147/CPAA.S112715
- By:
- Publication type:
- Article
4
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 133, doi. 10.2147/CPAA.S144606
- By:
- Publication type:
- Article
5
Antipsychotic prescription to identify delirium: results from two cohorts.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 113, doi. 10.2147/CPAA.S138441
- By:
- Publication type:
- Article
6
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 101, doi. 10.2147/CPAA.S138414
- By:
- Publication type:
- Article
7
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 159, doi. 10.2147/CPAA.S130178
- By:
- Publication type:
- Article
8
NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 79, doi. 10.2147/CPAA.S140057
- By:
- Publication type:
- Article
9
Etanercept (Enbrel®) alternative storage at ambient temperature.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 87, doi. 10.2147/CPAA.S131832
- By:
- Publication type:
- Article
10
Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 73, doi. 10.2147/CPAA.S135846
- By:
- Publication type:
- Article
11
An integrated epidemiological and neural net model of the warfarin effect in managed care patients.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 55, doi. 10.2147/CPAA.S136243
- By:
- Publication type:
- Article
12
Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 45, doi. 10.2147/CPAA.S131351
- By:
- Publication type:
- Article
13
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 19, doi. 10.2147/CPAA.S115687
- By:
- Publication type:
- Article
14
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 65, doi. 10.2147/CPAA.S133815
- By:
- Publication type:
- Article
15
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 39, doi. 10.2147/CPAA.S127502
- By:
- Publication type:
- Article
16
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 9, doi. 10.2147/CPAA.S119676
- By:
- Publication type:
- Article
17
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 1, doi. 10.2147/CPAA.S120032
- By:
- Publication type:
- Article
18
Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 29, doi. 10.2147/CPAA.S119875
- By:
- Publication type:
- Article